8-K
filed November 2, 2022, 7:59 PM ET
ticker CF
CIK 0001324404
earnings
confidence high
sentiment positive
materiality 0.80
CF Industries posts record 9M net earnings of $2.49B; announces $3B buyback, ExxonMobil CO2 capture deal
CF Industries Holdings, Inc.
2022-Q3 EPS reported
$12.04
revenue$8,578,000,000
- Q3 net earnings $438M ($2.18/diluted); 9M net earnings $2.49B ($12.04/diluted).
- Net sales Q3 $2.32B (+70% YoY); 9M $8.58B (+115% YoY).
- Board authorized new $3B share repurchase program through 2025, replacing $1.5B program.
- Commercial agreement with ExxonMobil to capture and store up to 2M tons CO2/year from Donaldsonville Complex; startup early 2025.
- Initiated FEED study with Mitsui for greenfield blue ammonia facility in Ascension Parish, LA; FID expected H2 2023.
Key facts
Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
CF Industries Holdings, Inc. reported the third quarter ended September 30, 2022 results: net income $438 million, EPS $2.18 per diluted share.
- Period
- the third quarter ended September 30, 2022
- Net income
- $438 million
- EPS
- $2.18 per diluted share
- Result
- reported results
Exact text from the filing
• Third quarter net earnings of $438 million (1) , or $2.18 per diluted share, EBITDA (2) of $826 million, and adjusted EBITDA (2) of $983 million
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
CF Industries Holdings, Inc. reported the first nine months ended September 30, 2022 results: revenue $8.58 billion, net income $2.49 billion, EPS $12.04 per diluted share.
- Period
- the first nine months ended September 30, 2022
- Revenue
- $8.58 billion
- Net income
- $2.49 billion
- EPS
- $12.04 per diluted share
- Result
- reported results
Exact text from the filing
For the first nine months of 2022, net earnings attributable to common stockholders were $2.49 billion, or $12.04 per diluted share, and EBITDA was $4.30 billion, which include the impact of pre-tax impairment and restructuring charges of $257 million related to the Company’s UK operations; adjusted EBITDA was $4.58 billion. These results compare to the first nine months of 2021 net earnings attributable to common stockholders of $212 million, or $0.98 per diluted share and EBITDA of $984 million, which included the impact of pre-tax impairment charges of $495 million related to the Company’s UK operations; and adjusted EBITDA of $1.49 billion. Net sales in the first nine months of 2022 were $8.58 billion compared to $4.00 billion in the first nine months of 2021.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.